National Institute on Aging; Notice of Closed Meetings, 21375 [E9-10600]
Download as PDF
Federal Register / Vol. 74, No. 87 / Thursday, May 7, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Prenatal
Programming.
Date: June 2, 2009.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Dennis E. Leszczynski,
PhD, Scientific Review Administrator,
Division of Scientific Review, National
Institute of Child Health, and Human
Development, NIH, 6100 Exeuctive Blvd.,
Rm. 5B01, Bethesda, MD 20892, (301) 435–
6884, leszczyd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: April 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–10607 Filed 5–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the Clinical Trials
Subcommittee of the National Advisory
VerDate Nov<24>2008
17:03 May 06, 2009
Jkt 217001
Neurological Disorders and Stroke
Council, previously scheduled for May
27, 2009, 6 p.m. to 7:30 p.m., Hyatt
Regency Bethesda, One Bethesda Metro
Center, 7400 Wisconsin Avenue,
Bethesda, MD 20814 which was
published in the Federal Register on
April 22, 2009, 74FRN18389.
The closed session of the Clinical
Trials Subcommittee meeting will now
be held on May 28, 2009 from 8 a.m. to
9:45 a.m. and the open session will be
held on May 28, 2009 from 9:45 a.m. to
10 a.m. in Building 31 on the NIH
Campus. The meeting is partially Closed
to the public.
Dated: April 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–10423 Filed 5–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Insulin and
IFG–1 Signaling Effects on Mouse Lifespan.
Date: June 11, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Building, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Elaine Lewis, PhD,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, Gateway
Building, Suite 2C212, MSC–9205, 7201
Wisconsin Avenue, Bethesda, MD 20892.
301–402–7707. elainelewis@nia.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Regulation of
Bone Mass Accrual by Serotonin.
Date: June 22, 2009.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
21375
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, 7201 Wisconsin
Avenue, Room 2C212, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, PhD,
Scientific Review Officer, National Institute
on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814.
301–402–7703. ferrellrj@mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Drug Development.
Date: July 7, 2009.
Time: 11:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building Room 2C–212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Parsadanian,
PhD, Scientific Review Officer, National
Institute on Aging, Gateway Building 2C/212,
7201 Wisconsin Avenue, Bethesda, MD
20892. 301–402–7703.
PARSADANIANA@NIA.NIH.GOV.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Evaluation of
Medicare.
Date: July 29, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Room 2C212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jeannette L. Johnson, PhD,
Scientific Review Officer, National Institutes
on Aging, National Institutes of Health, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7705,
JOHNSONJ9@NIA.NIH.GOV.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: April 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–10600 Filed 5–6–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Advisory Committee to the Director,
NIH.
The meeting will be open to the
public, with attendance limited to space
E:\FR\FM\07MYN1.SGM
07MYN1
Agencies
[Federal Register Volume 74, Number 87 (Thursday, May 7, 2009)]
[Notices]
[Page 21375]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10600]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Insulin and IFG-1 Signaling Effects on Mouse Lifespan.
Date: June 11, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Gateway Building, 7201
Wisconsin Avenue, Room 2C212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Elaine Lewis, PhD, Scientific Review Officer,
Scientific Review Branch, National Institute on Aging, Gateway
Building, Suite 2C212, MSC-9205, 7201 Wisconsin Avenue, Bethesda, MD
20892. 301-402-7707. elainelewis@nia.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Regulation of Bone Mass Accrual by Serotonin.
Date: June 22, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Aging, 7201 Wisconsin Avenue, Room 2C212, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Rebecca J. Ferrell, PhD, Scientific Review
Officer, National Institute on Aging, Gateway Building 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20814. 301-402-7703.
ferrellrj@mail.nih.gov.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Alzheimer's Disease Drug Development.
Date: July 7, 2009.
Time: 11:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on
Aging, Gateway Building Room 2C-212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Alexander Parsadanian, PhD, Scientific Review
Officer, National Institute on Aging, Gateway Building 2C/212, 7201
Wisconsin Avenue, Bethesda, MD 20892. 301-402-7703.
PARSADANIANA@NIA.NIH.GOV.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Evaluation of Medicare.
Date: July 29, 2009.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Room 2C212, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Jeannette L. Johnson, PhD, Scientific Review
Officer, National Institutes on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-
402-7705, JOHNSONJ9@NIA.NIH.GOV.
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: April 30, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-10600 Filed 5-6-09; 8:45 am]
BILLING CODE 4140-01-P